Starget Pharma develops a novel somatostatin-based targeted therapy platform.
Starget Pharma has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Starget Pharma is headquartered in Ramat Hasharon, Israel.
Starget Pharma develops a novel somatostatin-based targeted therapy platform.
Starget Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Starget Pharma — Funding & Investors." VCBacked, February 18, 2026, https://www.vcbacked.co/company/starget-pharma. Accessed July 19, 2026.
VCBacked. (2026). Starget Pharma — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/starget-pharma
{{cite web |title=Starget Pharma — Funding & Investors |url=https://www.vcbacked.co/company/starget-pharma |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated